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Background: The people of low and middle income countries bear about 80% of the global burden of diseases
that are attributable to high blood pressure. Hypertensive people contribute half of this burden; the rest is among
the people with lesser degrees of high blood pressure. Prehypertension elevates the risk of CVD, and that of end-stage
renal disease. Bangladesh is a developing country, with more than 75% of the population live in rural area. This study
aims to determine the prevalence and predictors of pre-hypertension and hypertension among the adults in rural
Bangladesh.
Methods: A cross-sectional study of major non-communicable disease risk factors (tobacco and alcohol use, fruit and
vegetable intake, physical activity) was conducted in rural surveillance sites of Bangladesh. In addition to the
self-reported information on risk factors, height and weight, and blood pressure were measured during household
visits using standard protocols of the WHO STEPwise approach to Surveillance. The study population included 6,094
men and women aged 25 years and above. Adjusted and unadjusted logistic regression analyses were performed to
evaluate the association of prehypertension and hypertension with various factors.
Results: The prevalence of pre-hypertension and hypertension was 31.9% and 16.0%, respectively. The men had a
higher prevalence (33.6%) of pre-hypertension compared to the women (30.3%). Multivariate analysis showed
that increasing age [OR 2.30 (1.84-2.87)] and higher BMI [OR 4.67 (3.35-6.51) were positively associated with
pre-hypertension. For hypertension, multivariate analysis showed that increasing age [OR 4.48 (3.38-5.94)] and
higher BMI (specially the overweight category) was positively associated.
Significant linear relationships of prehypertension were found with age [P for trend < 0.0001] and BMI [P for
trend < 0.0001]. Linear regression for hypertension shows significant association with age [P for trend < 0.0001]
but not with BMI [P for trend 0.3783].
Conclusion: Approximately one third and one-sixth of the adult population of rural Bangladesh are affected
with pre-hypertension and hypertension, respectively. This poses a great challenge ahead, as most of the people
with pre-hypertension will progress towards hypertension until otherwise undergo in any pharmacological or
lifestyle intervention.
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High blood pressure exerts a major share in the global
burden of disease, and it is unduly higher in the low income
countries than in the high income countries [1]. Hyperten-
sive people contributes half of this burden; the rest was
among the people with lesser degrees of high blood pres-
sure [2]. More specifically, elevated blood pressure is re-
sponsible for approximately 60% of stroke and over 50%
of ischemic heart disease [1]. Prehypertension elevates the
risk of CVD [3], and that of end-stage renal disease [4].
Prehypertension is associated with CVD mortality, espe-
cially stroke mortality [3] and stroke morbidity [5]. Pre-
hypertension is now recognized as a potential candidate
for cardiovascular intervention or risk reduction.
There is no definite lower threshold of blood pressure
for potential danger of cardiovascular mortality [6,7]. The
people with high normal blood pressure (systolic blood
pressures (SBP) from 120 to 139 mmHg and/or diastolic
blood pressures (DBP) from 80 and 89 mmHg) develop
hypertension faster and in an increased risk of cardio-
vascular disease [8,9]. The Seventh Report of the Joint
National Committee on Prevention, Detection, Evaluation,
and Treatment of High Blood Pressure (JNC 7), intro-
duced the new category of “pre-hypertension”, defined as
systolic BP of 120 to 139 mm Hg and/or diastolic BP of 80
to 89 mm Hg [10]. Recent studies found an association
between pre-hypertension and increased risk of Coronary
Artery Disease [11,12]. Follow up studies also reported
that prehypertension is an independent risk factor for car-
diovascular and cerebrovascular diseases [13]. A recent
meta-analysis reports that even lower range of prehyper-
tension is associated with higher risk of cardiovascular dis-
ease (CVD) [14]. Prehypertension is also associated with
chronic kidney diseases [15-17]. In USA, over 9% of death
and approximately 3.5% of hospitalizations are attributable
to pre-hypertension [18].
In USA, the prevalence of prehypertension ranged be-
tween 31% [19] to 48.2% [20]. In the neighbor country,
India, the prevalence stretched from 32% to 44% [21,22].
The prevalence is 21.9% in Chinese population [23].
Evidence now exists that prehypertension leads to the
development of frank hypertension [9,24], and that the de-
velopment of full blown hypertension can be prevented
with administering antihypertensive medications to the
patients with prehypertension [25,26]. On the basis of the
7th JNC, pre-hypertension necessitates daily life adjust-
ments to prevent development to hypertension [10].
Bangladesh is a low income, developing country, where
more than 75% of the population lives in rural area. There
is no data reporting the prevalence of pre-hypertension
and the factors associated to it in Bangladesh. In this study
we aim to find the prevalence and identify predictors of
pre-hypertension among the adults in rural Bangladesh.
Additionally, we determined the prevalence and predictorsof hypertension among the study population. We also
compared the determinants for pre-hypertension and
hypertension.Methods
Ethical considerations
The study was conducted according to the principles
expressed in the Declaration of Helsinki. The protocol for
the Non Communicable Disease (NCD) risk factor survey
using the World Health Organization STEPwise approach
to Surveillance (WHO STEPS) [27] was approved by the
Scientific Board of the International Network for the
Demographic Evaluation of Populations and Their Health
in Developing Countries (INDEPTH Network) and was
also in accordance with the ethics codes of surveillance
sites of International Centre for Diarrhoeal Diseases Research,
Bangladesh (ICDDR,B). Ethical approval was also obtained
from the Human Research Ethics Committee, The University
of Newcastle, Australia.
Both verbal and written informed consent was obtained
from the study participants, and they had the right to
withdraw themselves from the study at any time.Setting and sample size
The study population was obtained from three rural
demographic surveillance sites, Matlab, Abhaynagar and
Mirsarai. In Matlab Upazila (subdistrict), ICDDR,B has
been maintaining a Health and Demographic Surveillance
System (HDSS) since 1966 [28]. Matlab is a rural area lo-
cated about 55 km southeast of Dhaka. The Health and
Demographic Surveillance site Abhoynagar is located in
the south-western part with a total surveillance population
34,717 and Mirsarai, with a surveillance population 39,025,
is located in the south-eastern part of Bangladesh [29].
The HDSS provided the sampling frame for our study.
Data for this study was taken from the NCD risk factors
survey conducted in Bangladesh in 2005 as part of the 9
HDSS areas in 5 Asian countries using the WHO STEPS
methodology. The detail method has been described else-
where [30-32]. Briefly, the STEPS approach is composed
of 3 steps: structured questionnaire, physical measure-
ments, followed by biochemical analysis of blood samples.
In a representative sample of adults aged 25 to 64 years,
first two phases of STEPS were implemented in each sur-
veillance sites. Total sample size calculated is 2000 X 3.
Considering the possibility of large number of males being
absent at the daytime, a sample of 2800 X 3 males and fe-
males was drawn from this population. In each 10-year
range age group there were 350 samples per site with
equal number of males and females. All consenting adults
were interviewed. Absentees were approached three times,
when unsuccessful, were excluded from the study. The
participation rate in this study is 72.55%.
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Questionnaires were translated into Bangla from English
and then back translated to English identify the consisten-
cies. Questionnaires were pretested in the field in a pilot
phase, before the actual data collection. Six skilled field
workers per site were recruited for the study and re-trained
on standard methods of obtaining physical measurements.
To ensure the quality of data, independent field worker
checked 3% of data and held periodic meetings to provide
necessary feedback to the field workers.Measurements
Blood pressure was measured using digital blood pres-
sure measurement devices (Omron M3). Blood pressure
was measured and recorded during household visits fol-
lowing the STEPS methods (at the right arm at heart
level after a period of 5 minutes of rest). The averages of
the last two measurements, from the three readings, were
used in the analysis.
Participants were with lightweight wears and barefooted
during measuring their weight and height. Electronic
scales (Seca Gmbh, Hamburg, Germany) were placed at
flat surface to measure weight (to the nearest 10 grams).
Height was measured using portable stadiometer (to the
nearest 0.1 cm). Waist circumference was measured by
putting the measuring tape at the midpoint between the
lower margin of the last rib and the top of the hip bone
(at the level of umbilicus) at the end of expiration. Non-
elastic tape (Seca Gmbh, Hamburg, Germany) was used to
measure waist circumference, to the nearest 0.1 cm.
During the household visits, questionnaires on tobacco
smoking and chewing, intake of fruit and vegetable and
patterns of physical activities were administered. For to-
bacco consumption, information on current and ever
smoking along with use of smokeless tobacco (tobacco
leaf, goul, noshi, and zarda) were collected. Participants
were asked about their fruits and vegetables consumption
in a typical week, number of days and the number of serv-
ings on those days was collected. We have analysed fruits
and vegetable consumption as number of times per week.
The Global Physical Activity Questionnaire Version 2
was used to collect the information on physical activities
[33]. We have used the asset index data as substitute for
socio-economic status, collected separately from the sur-
veillance database of HDSS.Definitions
Pre-hypertension: Pre-hypertension was defined as a sys-
tolic blood pressures between 120 to 139 mmHg and/or
a diastolic blood pressures between 80 and 89 mmHg
according to the 7th report of JNC [10].
Hypertension: Hypertension was defined if the systolic
blood pressure was ≥140 mm Hg and/ or the diastolic bloodpressure was ≥90 mmHg, or if the participants were tak-
ing antihypertensive medicine [10].
Asset index: Detail calculation of the asset index is
available elsewhere [34]. Briefly, household assets and
housing characteristics, such as beddings, kitchenware &
utensils, furniture & cupboards, radio, television, bicycle,
boat, cows and electricity were considered in calculating
asset index. A single variable was produced combining
these asset characteristics, and ranked in ascending order.
The poverty quintiles were then developed by dividing this
variable into 5 equal groups.
Body mass index (BMI): BMI is calculated using the for-
mula, the weight in kilograms divided by the square of the
height in meters (kg/m2). BMI was categorized into four
groups as <18.5, 18.5-22.9, 23.0-27.4 and ≥27.5 kg/m2.
Statistical analysis plan
Descriptive analysis was performed for the socio-demographic
and other predictive factors. For continuous and categor-
ical variables, mean (standard deviation, SD) and pro-
portion were calculated, respectively. The prevalence of
prehypertension and hypertension were calculated. The
age of the sample population was categorized into five
groups (25–39, 40–49, 50–59 and 60+ years). Chi-square
statistics was used to compare categorical variables. Ad-
justed and unadjusted logistic regression analyses were
performed to evaluate the association of prehypertension
and hypertension with various factors. Odds ratios (OR)
and 95% confidence intervals (CI) were calculated, p < 0.05
was used as the level of significance. In the multivariate
analysis we have adjusted for the covariates age, sex, educa-
tion, asset index, smoking, tobacco chewing, fruit intake,
vegetable consumption, physical activities and BMI. SAS
(Version 8) Statistical software was used for the analysis.
Results
Table 1 shows the prevalence and distribution of pre-
hypertension and hypertension by demographic and socio-
economic status among the adults of rural Bangladesh.
The prevalence of pre-hypertension and hypertension are
31.9% and 16.0%, respectively. The mean age is also differ-
ent among normotensive (42.1 years), pre-hypertensive
(44.5 years) and hypertensive (50.1 years) groups (p <
0.0001) (Table 1).
As with pre-hypertension, the prevalence of hyperten-
sion also increases with age (Figure 1).
The prevalence of pre-hypertension was higher in the
men (33.6%) compared to the women (30.3%) (p < 0.0001).
On the contrary, the prevalence of hypertension was
higher among the women (18.4%) compare to the men
(13.5%) (p < 0.0001) (Figure 2).
The prevalence did not vary significantly by education
categories, but mean years of education are different be-
tween the pre-hypertensive (4.2 years) and the hypertensive
Table 1 Distribution of pre-hypertension and hypertension by socio-economic and lifestyle factors among the adults of
Rural Bangladesh* (n = 6094)
Characteristics Normotension
<120/80 mmHg
N = 3,176
Pre-hypertension
120-139 or 80-89 mmHg
N = 1,946
Hypertension
≥140 or ≥ 90 mmHg
N = 972
p-value
Prevalence 52.1 31.9 16
Age, 25-39 44.0 37.3 16.9
40-49 28.3 24.8 25.5
50-59 20.6 25.3 35.6
60 and above 7.3 12.6 22.1 <0.0001
Mean (SD) 42.1(10.9) 44.5(11.6) 50.1(10.3) <0.0001
Sex men 51.0 52.8 42.6 <0.0001
Education
No 41.9 40.6 45.3
Primary 28.2 26.6 26.2
Secondary 22.2 23.6 20.1
Higher secondary 4.0 4.4 4.1
Higher 3.7 4.8 4.3 0.9092
Mean( SD) 3.8(4.3) 4.2(4.5) 3.8(4.4) 0.0139
Asset Index
Poorest 16.3 12.4 13.2
Poorer 19.8 14.6 15.7
Middle 19.1 19.1 19.9
Less poor 19.9 23.1 19.0 <0.0001
Least poor 25.0 30.8 32.2
Smoking 31.3 29.5 20.1 <0.0001
Chewing 35.9 34.4 40.1 0.0092
Fruit intake, Mean (SD) 2.6(4.2) 2.6(4.2) 2.2(3.9) 0.0138
Vegetable intake, Mean (SD) 15.1(9.3) 15.6(9.1) 14.1(9.1) 0.0006
Physical activity (min per day)
Walking (SD) 36.1(61.9) 34.4(59.5) 26.3(50.5) <0.0001
Moderate (SD) 77.3(134.2) 79.4(132.4) 60.2(113.1) 0.0004
Heavy (SD) 23.9(87.0) 19.5(76.5) 12.2(61.2) 0.0003
BMI
<18.5 33.3 22.1 22.7
18.5-22.9 50.4 48.6 43.2
23.0-27.4 14.0 22.7 25.8
≥27.5 2.2 6.6 8.2 <0.0001
Mean ± SD 20.5(8.3) 21.8(7.9) 22.1(7.1) <0.0001
*Results are expressed as percent, unless otherwise indicated.
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hypertension increases with increasing wealth. There is
a difference between the prevalence of pre-hypertension
and hypertension for smoking, tobacco chewing, fruit con-
sumption, vegetable consumption, and different levels of
physical activity (Table 1).
The prevalence of the pre-hypertension and hyperten-
sion is different among the BMI categories (p < 0.0001)(Table 1). The prevalence of the pre-hypertension was
48.8%, highest in the BMI category of 23.0-27.4 (over-
weight by the WHO standard for the Asian people), and
46% in the BMI category ≥27.5. In the lowest BMI cat-
egory (<18.5) the prevalence of hypertension was 13% and
the prevalence increases with increasing BMI (Figure 3).
Multivariate analysis showed that increasing age, male
sex and higher BMI were positively, and fruit consumption
61
55.1
43.8
33.4
31.8
28.7
33
35.6
7.2
15.2
23.2
31.1
0 10 20 30 40 50 60 70
25-39
40-49
50-59
60+
Percentage distribution (%)
A
ge
 G
ro
up
s,
 y
ea
rs
Hypertension
Pre-hypertension
Normotension
Figure 1 Percentage distribution of Normotension, pre-hypertension and hypertension by age groups among the adults of rural Bangladesh.
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hypertension (Table 2). Comparing the predictors for hyper-
tension, multivariate analysis showed that increasing age
and higher BMI (specially the overweight category) was
positively associated (Table 2).
Significant linear relationships of prehypertension was
found with age [OR 1.019 (1.014-1.024)] (p < 0.0001) and
BMI [OR1.027 (1.015-1.039) ( p < 0.0001). Linear regres-
sion for hypertension shows significant association with
age [OR1.046 (1.038-1.054) (p < 0.0001) but not with
BMI [OR 1.004 (0.995-1.014) (p = 0.3783).
Discussion
This is the first study in Bangladesh reporting the preva-
lence and predicting factors of pre-hypertension among
the rural people of Bangladesh. This study also reports the
prevalence and associated factors related to hypertension.
Increasing age, male sex and higher BMI are positively as-
sociated with pre-hypertension. Studying the predictors for
hypertension compared with pre-hypertension, multivari-
ate analysis showed that increasing age and higher BMI
(specially the overweight category) are positively associ-
ated. The prevalence of pre-hypertension was signifi-
cantly higher among the men (33.6%) compared to women
(30.3%) in this population. This finding is consistent with
other findings [35,36]. The prevalence of hypertension was
higher in women compared to men, consistent with other
findings [37]. Therefore, opportunity may exist to target
men and thus protect them from developing frank hyper-
tension. We observed a low prevalence of prehypertension
but high prevalence of hypertension among female in this
population, this deserves further exploration, if hormonal
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Figure 3 Percentage distribution of normotension pre-hypertension and hypertension by BMI among the adults of rural Bangladesh.
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hypertension quickly before going through pre-hypertension
phase, and thus making women more vulnerable to hyper-
tension related target organ damage. This also indicates
that focus regarding controlling of hypertension should be
in practice for this group to avoid complications from
hypertension.
In this study, we have found that increasing age is an
independent risk factor for pre-hypertension and hyper-
tension. Other studies also found that age is a significant
risk factor for pre-hypertension [24]. The observed associ-
ation between age and hypertension is well reported [35,38].
Age is an un-modifiable risk factor; therefore other modi-
fiable risk factors should be controlled through some in-
terventions. For example, controlling weight may counter
the age effect and delay the progression to hypertension.
Increasing BMI is found to be an independent and
important risk factor for both pre-hypertension and hyper-
tension in this study. Relationship of higher BMI with pre-
hypertension was also observed in other studies [35,39]
and the association of high BMI and hypertension is
well established [38,40]. Increasing BMI, even the normal
range compared to the below normal range, is associated
with pre-hypertension. Evidence exist that overweight and
obesity are the strongest predictor of prehypertension
[41,42]. BMI is the robust predictor of pre-hypertension,
odds ratio of obese category is the highest among all
the significant predictors (OR 4.67, CI 3.35-6.51). In this
study, only the overweight category is associated with hyper-
tension when compared with people with pre-hypertension.
There is a clear relationship between body weight with
pre-hypertension and hypertension in this study popula-
tion. Body weight is the balance between consumption
and expenditure of energy. Further research is needed toexamine the role of diet and effect of physical activity on
pre-hypertension and hypertension in this population.
In our study, the better off (least poor) people are more
likely to be pre-hypertensive. The relationship between
poverty quintile and hypertension is similar in this study.
Cohort studies confirmed that the risk of cardiovascu-
lar mortality starts with blood pressure level as low as
115/75 mm Hg and increases in a linear approach for
every 20/10 mm Hg rise of blood pressure [8]. Recognizing
and classifying individuals with pre-hypertension directs us
to concentrate on individuals with increased CVD risk and
in whom valuable therapeutic interventions are to apply to
prevent or delay the onset of hypertension [43].
Prehypertension is now recognized as an important pub-
lic health problem. Nevertheless, the prevalence of prehy-
pertension varies considerably in different countries, which
may be due to ethnicity, as well as various local factors,
such as climate and lifestyle. Less is known about the fac-
tors associated with prehypertension among the Asian
people, let alone Bangladeshis. Prehypertension increases
the risk of cardiovascular diseases, and many a times clus-
tered with other risk factors, such as BMI. It is now known
that Asians developed CVD at a lower level of BMI com-
pared to the Caucasians.
Our findings may not be generalized for the whole
country, as data comes from the HDSS, which provide
mainly surveillance system in rural settings. Nonetheless,
75% of the population lives in rural area in Bangladesh
[44]. We have used the self-reported information on to-
bacco use, physical activity, fruit & vegetable consump-
tion, which might have compromised the validity.
There were several strengths in this study. The rural
surveillance sites cover a wide geographical area and scat-
tered throughout the country. The accuracy of our finding
Table 2 Comparison of predicting risk factors for Prehypertension (vs. Normotension) and Hypertension (vs.
Prehypertension) Groups
Adjusted OR (95% CI)
Risk factors Prehypertension vs normotensive Hypertension vs pre hypertension
Age
25-39 yrs (reference)
40-49 1.067(0.914 - 1.246) 2.517(1.965 -3.225)
50-59 1.517(1.286 - 1.789) 3.642(2.853 - 4.649)
60 and above 2.295(1.835 - 2.870) 4.480(3.380 - 5.939)
Sex
Female (reference)
Male 1.198(1.014 - 1.417) 0.927(0.732 - 1.174)
Education
No (reference)
Primary 0.865(0.742 - 1.008) 1.060(0.856 - 1.313)
Secondary 0.902(0.756 - 1.076) 1.092(0.846 - 1.410)
Higher secondary 0.768(0.552 - 1.068) 1.408(0.881 – 2.249)
Higher 0.936(0.670 - 1.309) 1.246(0.784 - 1.982)
Quintiles
Poorest (reference)
Poorer 0.958(0.769 - 1.194) 0.990(0.720 - 1.361)
Middle 1.216(0.982 - 1.506) 0.940(0.694 - 1.273)
Less poor 1.335(1.078 - 1.655) 0.691(0.508 - 0.942)
Least poor 1.248(1.000 - 1.556) 0.817(0.598 - 1.116)
BMI
<18.5 (reference)
18.5-22.9 1.519(1.311 - 1.760) 1.033(0.830 - 1.287)
23.0-27.4 2.459(2.028 – 2.980) 1.362(1.051 - 1.764)
≥27.5 4.667(3.346 – 6.510) 1.441(0.999 - 2.079)
Smoking
Not smoking (reference)
Currently smoking 0.894(0.755 - 1.057) 0.683(0.534 – 0.874)
Chewing
Not chewing (reference)
Currently chewing 0.86(0.75 – 0.98) 0.89(0.74 - 1.07)
Fruit consumption 0.98(0.97 – 1.00) 0.99(0.97 – 1.01)
Vegetable consumption 1.00(0.99 – 1.01) 0.99(0.98 – 1.00)
Physical activity
Walking 1.00(1.00 - 1.00) 0.999(0.997 - 1.001)
Moderate 1.00(1.00 - 1.00) 0.999(0.998 - 1.000)
Heavy 1.00(1.00 - 1.00) 0.999(0.998 - 1.001)
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veillance population is well informed and accustomed
about the timely data collection and a high response rate
is generally observed. The data comes from the HDSS,
which helped us to measure the prehypertension burdenamong the surveillance population, whereby researchers
may follow this group to predict future patterns of hyper-
tensive diseases, along with stroke and other cardiovascu-
lar diseases; where it will be easy to monitor being under
the surveillance system.
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Approximately one third of the adult population of rural
Bangladesh is affected with pre-hypertension and one
sixth is affected with hypertension. This places a great
challenge ahead. Serious evaluation of this at-risk group
is highly warranted. People with pre-hypertension can
serve as a group to guide valuable interventions to con-
trol and prevent cardiovascular diseases.
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